This e-newsletter features summaries of selected key abstracts from the 2024 ASH Annual Meeting. Numerous abstracts addressed key developments in AML, offering insights into novel agents, optimized treatment combinations, and mechanisms of resistance.

Click here to read additional abstract summaries in AML.

This e-newsletter highlights new strategies—from innovative combination regimens to emerging immunotherapies—that hold promise in improving outcomes for this challenging AML patient population.

View the entire accredited panel discussion here.

This e-newsletter highlights current and emerging treatment strategies, practical advice for patient management, and the importance of collaborative care between community oncologists and specialized centers.

View the entire accredited panel discussion here.

Read a summary of current and emerging treatment strategies, patient assessment, and the role of genetic testing in managing AML.

View the entire accredited panel discussion here.

This e-newsletter features summaries of selected key abstracts from the EHA 2024 Annual Meeting. These summaries provide key takeaways from the meeting, highlighting the importance of staying informed about the latest research in AML to enhance clinical practice and patient care.

Click here to read additional abstract summaries in AML.

This e-newsletter features summaries of selected key abstracts from the ASCO 2024 Annual Meeting. These summaries provide key takeaways from the meeting, highlighting the importance of staying informed about the latest research in AML to enhance clinical practice and patient care.

Click here to read additional abstract summaries in AML.